Clinical Trials · NCT01801397
A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- University of Zurich
- Enrollment
- 10
- Start date
- Mar 2014
- Locations
- 2 sites, Switzerland
- Primary endpoint
- To assess the efficacy of Teriparatide (Forsteo®) in increasing the bone mineral density in the lumbar spine, total hip and femoral neck in patients with anorexia nervosa and low bone density at months 12 and 24.